Modalis Therapeutics Corporation closed the private placement of 1st series of unsecured convertible bonds with stock acquisition rights and the 12th stock acquisition rights on November 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70 JPY | 0.00% |
|
0.00% | -43.55% |
1st Jan change | Capi. | |
---|---|---|
-43.55% | 16.48M | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- 4883 Stock
- News Modalis Therapeutics Corporation
- Modalis Therapeutics Corporation announced that it has received ¥505.320864 million in funding from Evolution Capital Management LLC